NO995245D0 - Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for Õ behandle sykdommer som bevirker demyelinisering - Google Patents

Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for Õ behandle sykdommer som bevirker demyelinisering

Info

Publication number
NO995245D0
NO995245D0 NO995245A NO995245A NO995245D0 NO 995245 D0 NO995245 D0 NO 995245D0 NO 995245 A NO995245 A NO 995245A NO 995245 A NO995245 A NO 995245A NO 995245 D0 NO995245 D0 NO 995245D0
Authority
NO
Norway
Prior art keywords
group
alkyl
alkoxy
phenyl
alkoxycarbonyl
Prior art date
Application number
NO995245A
Other languages
English (en)
Other versions
NO995245L (no
NO325163B1 (no
Inventor
Bernard Bourrie
Pierre Casellas
Jean-Pierre Maffrand
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO995245D0 publication Critical patent/NO995245D0/no
Publication of NO995245L publication Critical patent/NO995245L/no
Publication of NO325163B1 publication Critical patent/NO325163B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO19995245A 1997-04-29 1999-10-27 Anvendelse av tetrahydropyridinderivater NO325163B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705275A FR2762514B1 (fr) 1997-04-29 1997-04-29 Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
PCT/FR1998/000774 WO1998048802A1 (fr) 1997-04-29 1998-04-17 Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation

Publications (3)

Publication Number Publication Date
NO995245D0 true NO995245D0 (no) 1999-10-27
NO995245L NO995245L (no) 1999-12-27
NO325163B1 NO325163B1 (no) 2008-02-11

Family

ID=9506415

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995245A NO325163B1 (no) 1997-04-29 1999-10-27 Anvendelse av tetrahydropyridinderivater

Country Status (18)

Country Link
US (1) US6344464B1 (no)
EP (1) EP0979079B1 (no)
JP (1) JP3956059B2 (no)
AR (1) AR012504A1 (no)
AT (1) ATE269077T1 (no)
AU (1) AU7436498A (no)
BR (1) BR9810234A (no)
CA (1) CA2288241C (no)
DE (1) DE69824576T2 (no)
DK (1) DK0979079T3 (no)
ES (1) ES2222593T3 (no)
FR (1) FR2762514B1 (no)
NO (1) NO325163B1 (no)
PT (1) PT979079E (no)
SI (1) SI0979079T1 (no)
UY (1) UY24973A1 (no)
WO (1) WO1998048802A1 (no)
ZA (1) ZA983602B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
FR2823748B1 (fr) * 2001-04-20 2004-02-20 Sanofi Synthelabo Tetrahydropyridyl-alkyl-benzodiazines, procede pour leur preparation et compositions pharmaceutiques les contenant
JP4324382B2 (ja) * 2001-04-20 2009-09-02 サノフィ−アベンティス テトラヒドロピリジル−アルキル−複素環、その製造方法およびそれを含む医薬組成物
JP4212470B2 (ja) 2001-06-26 2009-01-21 アムジェン フレモント インク． Ｏｐｇｌへの抗体
EP1414517A4 (en) * 2001-06-26 2008-02-06 Photomed Technologies Inc MULTIPLE WAVELENGTH ILLUMINATOR
FR2831166B1 (fr) * 2001-10-18 2004-02-27 Sanofi Synthelabo Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant
ATE549033T1 (de) 2002-09-06 2012-03-15 Amgen Inc Therapeutischer menschlicher monoklonaler anti-il-1r1-antikörper
CA2511823A1 (en) * 2002-12-30 2004-07-22 Amgen Inc. Combination therapy with co-stimulatory factors
US7838522B2 (en) 2004-11-17 2010-11-23 Ares Trading S.A. Benzothiazole formulations and use thereof
AU2005318163B2 (en) 2004-12-21 2011-12-01 Merck Serono Sa Sulfonyl amino cyclic derivatives and use thereof
PT1844032E (pt) 2005-01-31 2011-07-27 Merck Serono Sa Derivados n-hidroxiamida e sua utilização
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
MX2008000665A (es) * 2005-07-15 2008-03-13 Serono Lab Inhibidores de proteina epitelial glomerular 1 en el tratamiento de trastornos autoinmunes y/o inflamatorios.
KR20080050591A (ko) 2005-09-01 2008-06-09 아레스 트레이딩 에스.에이. 시신경염 치료
WO2009067621A1 (en) * 2007-11-21 2009-05-28 Decode Genetics Ehf Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
KR101707597B1 (ko) * 2010-12-07 2017-02-17 한국전자통신연구원 홀 센서리스 ｂｌｄｃ 모터용 전원 공급 모듈
EP3836954A1 (en) 2018-08-13 2021-06-23 Iltoo Pharma Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
WO2023118544A1 (en) 2021-12-23 2023-06-29 Cilcare Dev 4-phenyl-tetrahydropyridine derivatives for treating hearing diseases
WO2023222565A1 (en) 2022-05-16 2023-11-23 Institut National de la Santé et de la Recherche Médicale Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531707A1 (fr) 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
FR2662355B1 (fr) 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
FR2740343B1 (fr) 1995-10-26 1999-01-22 Sanofi Sa Utilisation de la 1-(2-napht-2-yl-ethyl)-4- (3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de la sclerose laterale amyotrophique

Also Published As

Publication number Publication date
SI0979079T1 (en) 2004-10-31
NO995245L (no) 1999-12-27
AR012504A1 (es) 2000-10-18
DK0979079T3 (da) 2004-10-25
EP0979079B1 (fr) 2004-06-16
FR2762514A1 (fr) 1998-10-30
DE69824576D1 (de) 2004-07-22
ATE269077T1 (de) 2004-07-15
ZA983602B (en) 1998-11-02
FR2762514B1 (fr) 1999-10-22
JP3956059B2 (ja) 2007-08-08
PT979079E (pt) 2004-10-29
US6344464B1 (en) 2002-02-05
AU7436498A (en) 1998-11-24
WO1998048802A1 (fr) 1998-11-05
ES2222593T3 (es) 2005-02-01
CA2288241C (en) 2006-10-03
CA2288241A1 (en) 1998-11-05
BR9810234A (pt) 2000-09-19
JP2002501498A (ja) 2002-01-15
EP0979079A1 (fr) 2000-02-16
UY24973A1 (es) 1998-07-16
NO325163B1 (no) 2008-02-11
DE69824576T2 (de) 2005-06-30

Similar Documents

Publication Publication Date Title
NO995245D0 (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for Õ behandle sykdommer som bevirker demyelinisering
KR970704435A (ko) 헤테로시클릭 화합물의 도파민-D 리간드로서의 용도(Use of Heterocyclic Compounds as Dopamines-D Ligands)
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
HUP0301690A2 (hu) Szinergikus eljárások és készítmények rák kezelésére
NO944911L (no) Ikke-peptid-takykininreseptorantagonister
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
NO20062491L (no) Benzoksazinderivter og deres anvendelse
ES2062165T3 (es) Derivado de piperidina, metodo para su preparacion, y una composicion farmaceutica que comprende el mismo.
RU2003128068A (ru) 2-тиозамещенные производные имидазола и их применение в фармации
ATE400552T1 (de) 4,4' -dithiobis- (3-aminobutane-1-sulfonate)- derivate und sie enthaltende zusammensetzungen
NO20054360L (no) Nye oxazolderivater, deres fremstilling og anvendelse som farmasotiske preparater
ATE237614T1 (de) Benzo(c)chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren
NO961797L (no) Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
HK1083197A1 (en) A pharmaceutical formulation and its use in the treatment of inner ear diseases
IL149306A0 (en) Benzamidine derivatives and pharmaceutical compositions containing the same
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
IS3887A (is) Lyfjablanda til þess að lækka háan blóðþrýsting, aðferð til framleiðslu hennar og notkunar sem lyfs
TW200509915A (en) Novel oxazoles, their manufacture and use as pharmaceutical agents
NO992869D0 (no) 1-Fenylalkyl-1,2,3,6-tetrahydropyridiner for behandling av Alzheimer's sykdom